Market Trends of Pharmaceutical Blister Packaging Industry
This section covers the major market trends shaping the Pharmaceutical Blister Packaging Market according to our research experts:
Innovation for New Recyclable Materials Shaping the Market
- As the environmental laws become more stringent, pharmaceutical packaging vendors are looking for better recyclability of materials used for blister packaging. Presently, most blister packaging involves heavy use of materials, like PVC, PVDC, foil, etc. These also include single-use plastics, which cannot be recycled or composted and harm the environment. Hence, companies are developing new recyclable thermoformed plastic solutions and materials for kidding films about supporting the recyclability of the blister packages.
- Several companies are coming up with new packaging recyclable materials for blister packaging. For instance, AmSky Blister System offered by Amcor PLC is a recyclable alternative to existing blister packaging solutions. AmSky features a vinyl and aluminum-free thermoform system and is based on PE for recycling in rigid and flexible recycling streams. Amcor uses UV Flexo Multi GIages, its patented child-resistant/senior-friendly solution, offering a moisture barrier for the security of supply. The clinical trials of the solutions have already begun, making them available in the market by the second half of 2022.
- Governments are boosting the ban on non-biodegradable plastics and other environmentally-hazardous materials, which will affect the film materials and thermoform options used in the pharmaceutical blister packaging. For instance, in June 2022, the public information bureau (PIB) requested the states to ban Single-Use Plastics (SUP) under the "Clean and Green" campaign launched by the Ministry of Housing and Urban Affairs. The ban aims to stop manufacturing products containing SUPs completely by July 2022.
- The increasing spending on medicine fuels the concern for the material used in blister packaging the pharmaceuticals. The widespread demand for medicine makes it critical if more non-recyclable materials are used in the process, making it difficult to recycle later. Government initiatives like European Plastics Pact operate at a mass level, addressing households, hospitality, industries, retailers, etc., to boost the recyclable materials on a wider and more effective scale, banning the use of SUPs. Such measures also validate the shift to recyclable alternatives in the blister packaging sector for the long run.
- With the increasing consumption of medicines protected and transported through blister packaging and government laws promoting the use of recyclable materials, the blister packaging CDMOs and CMOs are looking forward to altering the form-fill-seal and other production line equipment according to the future of the industry. Thus, the use of recyclable materials, including paperboard, PET, aluminum, etc., will rise, affecting the packaging firms and film suppliers.
Understand The Key Trends Shaping This Market
Download PDF
Increasing Drug Consumption to Drive the Market
- The amount of medicines consumed is increasing globally with each passing year. Since the manufacture of medicines is ever-increasing, catering to the discoveries of diseases and their remedies, the demand for packaging is impacted directly. The need for flexible packaging options like blister packaging is among the most preferred methods, as they profile tamper-free, leak-proof packaging options, which can be implemented for bulk operations to attain fast and reliable packaging.
- The increased supply of Active Pharmaceutical Ingredients (APIs) has also increased the demand for blister packaging. The new developments in the number of API manufacturing and development facilities are boosting the demand for blister packaging components. For instance, in May 2022, Pfeifer announced the operationalization of its only drug development center in Asia, a 61,000 sq. ft. facility located in Chennai, Tamil Nadu, India. The Investment of USD 20 million is dedicated to developing the company's offerings, including APIs and Finished Dosage forms (FDFs). Three of the company's manufacturing plants in India will benefit from the progress made in APIs by such facilities.
- The increase in global spending on medicine impacts blister packaging positively. The developed countries display a better adoption rate for improved healthcare diagnostics and overall standards, including medicine, contributing to the medical spending. The development in drug access in developed and pharmerging countries has played a vital role in increasing drug consumption, driving the demand, and indirectly paving the scope for blister packaging in medicine. The evolution of e-commerce platforms has contributed to strengthening drug access and complying with the stringent regulations for safe logistics.
- Several government initiatives promote bulk drug manufacturing to meet the increasing demand for medicines. For instance, in May 2022, the Department of Pharmaceuticals (DoP) in India separated the items into three categories: formulations, biopharmaceuticals, bulk medications, and in-vitro diagnostic medical devices, among others, formulated a system for respective incentives to promote local manufacturing. On incremental sales, the first and second categories would receive a 10% reward, while the third would receive a 5% bonus. The government quoted that it would provide the scheme to up to 55 drugmakers with a total of Rs 15,000 crore in production-linked incentives over the following six years through FY29.
Get Analysis on Important Geographic Markets
Download PDF
